Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Selby, Joe"'
Autor:
Cooper, William O., Habel, Laurel A., Sox, Colin M., Chan, K. Arnold, Arbogast, Patrick G., Cheetham, T. Craig, Murray, Katherine T., Quinn, Virginia P., Stein, C. Michael, Callahan, S. Todd, Fireman, Bruce H., Fish, Frank A., Kirshner, Howard S., O’Duffy, Anne, Selby, Joe V., Connell, Frederick A., Ray, Wayne A.
Publikováno v:
New England Journal of Medicine. 365:1896-1904
Adverse-event reports from North America have raised concern that the use of drugs for attention deficit-hyperactivity disorder (ADHD) increases the risk of serious cardiovascular events.We conducted a retrospective cohort study with automated data f
Autor:
Califf RM; From the Office of the Commissioner (R.M.C., R.E.S.) and the Centers for Drug Evaluation and Research (M.A.R., J. Woodcock), Biologics Evaluation and Research (P.W.M.), and Devices and Radiological Health (J.S.), Food and Drug Administration, Silver Spring, the Office of the Director (A.B.B.) and the Center for Evidence and Practice Improvement (C.D.), Agency for Healthcare Research and Quality, Rockville, the National Center for Complementary and Integrative Health (J.P.B.), the Office of the Director (F.S.C.), and the National Center for Advancing Translational Sciences (P.K.) and Office of Extramural Research Activities (M.L.), National Institutes of Health, Bethesda, and the Centers for Medicare and Medicaid Services, Baltimore (P.H.C., A.M.S.) - all in Maryland; formerly the U.S. Army Office of the Surgeon General Pharmacovigilance Center, Falls Church, VA (T.S.C.); the Office of the Under Secretary for Health, Department of Veterans Affairs (D.J.S.), the Office of Health Policy, Office of the Assistant Secretary for Planning and Evaluation, (N.D.L., S.R.S.), the Office of the Assistant Secretary for Health (K.B.D.), and the Office of the National Coordinator for Health Information Technology (B.V.W., P.J.W.), Department of Health and Human Services, the National Academy of Medicine (V.J.D., J.M.M.), and the Patient-Centered Outcomes Research Institute (R.L.F., J.V.S.), Washington, DC; the Center for Medication Safety, Department of Veterans Affairs, Hines, IL (F.E.C.); the Department of Health Care Policy, Harvard University (R.G.F.), the Million Veteran Program, Veterans Affairs Boston Healthcare System-Division of Aging, Brigham and Women's Hospital and Harvard Medical School (J.M.G.), and the Department of Surgery, Boston University School of Medicine (J. Woodson), Boston; and the Office of Public Health Scientific Services, Centers for Disease Control and Prevention, Atlanta (C.R.)., Robb MA; From the Office of the Commissioner (R.M.C., R.E.S.) and the Centers for Drug Evaluation and Research (M.A.R., J. Woodcock), Biologics Evaluation and Research (P.W.M.), and Devices and Radiological Health (J.S.), Food and Drug Administration, Silver Spring, the Office of the Director (A.B.B.) and the Center for Evidence and Practice Improvement (C.D.), Agency for Healthcare Research and Quality, Rockville, the National Center for Complementary and Integrative Health (J.P.B.), the Office of the Director (F.S.C.), and the National Center for Advancing Translational Sciences (P.K.) and Office of Extramural Research Activities (M.L.), National Institutes of Health, Bethesda, and the Centers for Medicare and Medicaid Services, Baltimore (P.H.C., A.M.S.) - all in Maryland; formerly the U.S. Army Office of the Surgeon General Pharmacovigilance Center, Falls Church, VA (T.S.C.); the Office of the Under Secretary for Health, Department of Veterans Affairs (D.J.S.), the Office of Health Policy, Office of the Assistant Secretary for Planning and Evaluation, (N.D.L., S.R.S.), the Office of the Assistant Secretary for Health (K.B.D.), and the Office of the National Coordinator for Health Information Technology (B.V.W., P.J.W.), Department of Health and Human Services, the National Academy of Medicine (V.J.D., J.M.M.), and the Patient-Centered Outcomes Research Institute (R.L.F., J.V.S.), Washington, DC; the Center for Medication Safety, Department of Veterans Affairs, Hines, IL (F.E.C.); the Department of Health Care Policy, Harvard University (R.G.F.), the Million Veteran Program, Veterans Affairs Boston Healthcare System-Division of Aging, Brigham and Women's Hospital and Harvard Medical School (J.M.G.), and the Department of Surgery, Boston University School of Medicine (J. Woodson), Boston; and the Office of Public Health Scientific Services, Centers for Disease Control and Prevention, Atlanta (C.R.)., Bindman AB; From the Office of the Commissioner (R.M.C., R.E.S.) and the Centers for Drug Evaluation and Research (M.A.R., J. Woodcock), Biologics Evaluation and Research (P.W.M.), and Devices and Radiological Health (J.S.), Food and Drug Administration, Silver Spring, the Office of the Director (A.B.B.) and the Center for Evidence and Practice Improvement (C.D.), Agency for Healthcare Research and Quality, Rockville, the National Center for Complementary and Integrative Health (J.P.B.), the Office of the Director (F.S.C.), and the National Center for Advancing Translational Sciences (P.K.) and Office of Extramural Research Activities (M.L.), National Institutes of Health, Bethesda, and the Centers for Medicare and Medicaid Services, Baltimore (P.H.C., A.M.S.) - all in Maryland; formerly the U.S. Army Office of the Surgeon General Pharmacovigilance Center, Falls Church, VA (T.S.C.); the Office of the Under Secretary for Health, Department of Veterans Affairs (D.J.S.), the Office of Health Policy, Office of the Assistant Secretary for Planning and Evaluation, (N.D.L., S.R.S.), the Office of the Assistant Secretary for Health (K.B.D.), and the Office of the National Coordinator for Health Information Technology (B.V.W., P.J.W.), Department of Health and Human Services, the National Academy of Medicine (V.J.D., J.M.M.), and the Patient-Centered Outcomes Research Institute (R.L.F., J.V.S.), Washington, DC; the Center for Medication Safety, Department of Veterans Affairs, Hines, IL (F.E.C.); the Department of Health Care Policy, Harvard University (R.G.F.), the Million Veteran Program, Veterans Affairs Boston Healthcare System-Division of Aging, Brigham and Women's Hospital and Harvard Medical School (J.M.G.), and the Department of Surgery, Boston University School of Medicine (J. Woodson), Boston; and the Office of Public Health Scientific Services, Centers for Disease Control and Prevention, Atlanta (C.R.)., Briggs JP; From the Office of the Commissioner (R.M.C., R.E.S.) and the Centers for Drug Evaluation and Research (M.A.R., J. Woodcock), Biologics Evaluation and Research (P.W.M.), and Devices and Radiological Health (J.S.), Food and Drug Administration, Silver Spring, the Office of the Director (A.B.B.) and the Center for Evidence and Practice Improvement (C.D.), Agency for Healthcare Research and Quality, Rockville, the National Center for Complementary and Integrative Health (J.P.B.), the Office of the Director (F.S.C.), and the National Center for Advancing Translational Sciences (P.K.) and Office of Extramural Research Activities (M.L.), National Institutes of Health, Bethesda, and the Centers for Medicare and Medicaid Services, Baltimore (P.H.C., A.M.S.) - all in Maryland; formerly the U.S. Army Office of the Surgeon General Pharmacovigilance Center, Falls Church, VA (T.S.C.); the Office of the Under Secretary for Health, Department of Veterans Affairs (D.J.S.), the Office of Health Policy, Office of the Assistant Secretary for Planning and Evaluation, (N.D.L., S.R.S.), the Office of the Assistant Secretary for Health (K.B.D.), and the Office of the National Coordinator for Health Information Technology (B.V.W., P.J.W.), Department of Health and Human Services, the National Academy of Medicine (V.J.D., J.M.M.), and the Patient-Centered Outcomes Research Institute (R.L.F., J.V.S.), Washington, DC; the Center for Medication Safety, Department of Veterans Affairs, Hines, IL (F.E.C.); the Department of Health Care Policy, Harvard University (R.G.F.), the Million Veteran Program, Veterans Affairs Boston Healthcare System-Division of Aging, Brigham and Women's Hospital and Harvard Medical School (J.M.G.), and the Department of Surgery, Boston University School of Medicine (J. Woodson), Boston; and the Office of Public Health Scientific Services, Centers for Disease Control and Prevention, Atlanta (C.R.)., Collins FS; From the Office of the Commissioner (R.M.C., R.E.S.) and the Centers for Drug Evaluation and Research (M.A.R., J. Woodcock), Biologics Evaluation and Research (P.W.M.), and Devices and Radiological Health (J.S.), Food and Drug Administration, Silver Spring, the Office of the Director (A.B.B.) and the Center for Evidence and Practice Improvement (C.D.), Agency for Healthcare Research and Quality, Rockville, the National Center for Complementary and Integrative Health (J.P.B.), the Office of the Director (F.S.C.), and the National Center for Advancing Translational Sciences (P.K.) and Office of Extramural Research Activities (M.L.), National Institutes of Health, Bethesda, and the Centers for Medicare and Medicaid Services, Baltimore (P.H.C., A.M.S.) - all in Maryland; formerly the U.S. Army Office of the Surgeon General Pharmacovigilance Center, Falls Church, VA (T.S.C.); the Office of the Under Secretary for Health, Department of Veterans Affairs (D.J.S.), the Office of Health Policy, Office of the Assistant Secretary for Planning and Evaluation, (N.D.L., S.R.S.), the Office of the Assistant Secretary for Health (K.B.D.), and the Office of the National Coordinator for Health Information Technology (B.V.W., P.J.W.), Department of Health and Human Services, the National Academy of Medicine (V.J.D., J.M.M.), and the Patient-Centered Outcomes Research Institute (R.L.F., J.V.S.), Washington, DC; the Center for Medication Safety, Department of Veterans Affairs, Hines, IL (F.E.C.); the Department of Health Care Policy, Harvard University (R.G.F.), the Million Veteran Program, Veterans Affairs Boston Healthcare System-Division of Aging, Brigham and Women's Hospital and Harvard Medical School (J.M.G.), and the Department of Surgery, Boston University School of Medicine (J. Woodson), Boston; and the Office of Public Health Scientific Services, Centers for Disease Control and Prevention, Atlanta (C.R.)., Conway PH; From the Office of the Commissioner (R.M.C., R.E.S.) and the Centers for Drug Evaluation and Research (M.A.R., J. Woodcock), Biologics Evaluation and Research (P.W.M.), and Devices and Radiological Health (J.S.), Food and Drug Administration, Silver Spring, the Office of the Director (A.B.B.) and the Center for Evidence and Practice Improvement (C.D.), Agency for Healthcare Research and Quality, Rockville, the National Center for Complementary and Integrative Health (J.P.B.), the Office of the Director (F.S.C.), and the National Center for Advancing Translational Sciences (P.K.) and Office of Extramural Research Activities (M.L.), National Institutes of Health, Bethesda, and the Centers for Medicare and Medicaid Services, Baltimore (P.H.C., A.M.S.) - all in Maryland; formerly the U.S. Army Office of the Surgeon General Pharmacovigilance Center, Falls Church, VA (T.S.C.); the Office of the Under Secretary for Health, Department of Veterans Affairs (D.J.S.), the Office of Health Policy, Office of the Assistant Secretary for Planning and Evaluation, (N.D.L., S.R.S.), the Office of the Assistant Secretary for Health (K.B.D.), and the Office of the National Coordinator for Health Information Technology (B.V.W., P.J.W.), Department of Health and Human Services, the National Academy of Medicine (V.J.D., J.M.M.), and the Patient-Centered Outcomes Research Institute (R.L.F., J.V.S.), Washington, DC; the Center for Medication Safety, Department of Veterans Affairs, Hines, IL (F.E.C.); the Department of Health Care Policy, Harvard University (R.G.F.), the Million Veteran Program, Veterans Affairs Boston Healthcare System-Division of Aging, Brigham and Women's Hospital and Harvard Medical School (J.M.G.), and the Department of Surgery, Boston University School of Medicine (J. Woodson), Boston; and the Office of Public Health Scientific Services, Centers for Disease Control and Prevention, Atlanta (C.R.)., Coster TS; From the Office of the Commissioner (R.M.C., R.E.S.) and the Centers for Drug Evaluation and Research (M.A.R., J. Woodcock), Biologics Evaluation and Research (P.W.M.), and Devices and Radiological Health (J.S.), Food and Drug Administration, Silver Spring, the Office of the Director (A.B.B.) and the Center for Evidence and Practice Improvement (C.D.), Agency for Healthcare Research and Quality, Rockville, the National Center for Complementary and Integrative Health (J.P.B.), the Office of the Director (F.S.C.), and the National Center for Advancing Translational Sciences (P.K.) and Office of Extramural Research Activities (M.L.), National Institutes of Health, Bethesda, and the Centers for Medicare and Medicaid Services, Baltimore (P.H.C., A.M.S.) - all in Maryland; formerly the U.S. Army Office of the Surgeon General Pharmacovigilance Center, Falls Church, VA (T.S.C.); the Office of the Under Secretary for Health, Department of Veterans Affairs (D.J.S.), the Office of Health Policy, Office of the Assistant Secretary for Planning and Evaluation, (N.D.L., S.R.S.), the Office of the Assistant Secretary for Health (K.B.D.), and the Office of the National Coordinator for Health Information Technology (B.V.W., P.J.W.), Department of Health and Human Services, the National Academy of Medicine (V.J.D., J.M.M.), and the Patient-Centered Outcomes Research Institute (R.L.F., J.V.S.), Washington, DC; the Center for Medication Safety, Department of Veterans Affairs, Hines, IL (F.E.C.); the Department of Health Care Policy, Harvard University (R.G.F.), the Million Veteran Program, Veterans Affairs Boston Healthcare System-Division of Aging, Brigham and Women's Hospital and Harvard Medical School (J.M.G.), and the Department of Surgery, Boston University School of Medicine (J. Woodson), Boston; and the Office of Public Health Scientific Services, Centers for Disease Control and Prevention, Atlanta (C.R.)., Cunningham FE; From the Office of the Commissioner (R.M.C., R.E.S.) and the Centers for Drug Evaluation and Research (M.A.R., J. Woodcock), Biologics Evaluation and Research (P.W.M.), and Devices and Radiological Health (J.S.), Food and Drug Administration, Silver Spring, the Office of the Director (A.B.B.) and the Center for Evidence and Practice Improvement (C.D.), Agency for Healthcare Research and Quality, Rockville, the National Center for Complementary and Integrative Health (J.P.B.), the Office of the Director (F.S.C.), and the National Center for Advancing Translational Sciences (P.K.) and Office of Extramural Research Activities (M.L.), National Institutes of Health, Bethesda, and the Centers for Medicare and Medicaid Services, Baltimore (P.H.C., A.M.S.) - all in Maryland; formerly the U.S. Army Office of the Surgeon General Pharmacovigilance Center, Falls Church, VA (T.S.C.); the Office of the Under Secretary for Health, Department of Veterans Affairs (D.J.S.), the Office of Health Policy, Office of the Assistant Secretary for Planning and Evaluation, (N.D.L., S.R.S.), the Office of the Assistant Secretary for Health (K.B.D.), and the Office of the National Coordinator for Health Information Technology (B.V.W., P.J.W.), Department of Health and Human Services, the National Academy of Medicine (V.J.D., J.M.M.), and the Patient-Centered Outcomes Research Institute (R.L.F., J.V.S.), Washington, DC; the Center for Medication Safety, Department of Veterans Affairs, Hines, IL (F.E.C.); the Department of Health Care Policy, Harvard University (R.G.F.), the Million Veteran Program, Veterans Affairs Boston Healthcare System-Division of Aging, Brigham and Women's Hospital and Harvard Medical School (J.M.G.), and the Department of Surgery, Boston University School of Medicine (J. Woodson), Boston; and the Office of Public Health Scientific Services, Centers for Disease Control and Prevention, Atlanta (C.R.)., De Lew N; From the Office of the Commissioner (R.M.C., R.E.S.) and the Centers for Drug Evaluation and Research (M.A.R., J. Woodcock), Biologics Evaluation and Research (P.W.M.), and Devices and Radiological Health (J.S.), Food and Drug Administration, Silver Spring, the Office of the Director (A.B.B.) and the Center for Evidence and Practice Improvement (C.D.), Agency for Healthcare Research and Quality, Rockville, the National Center for Complementary and Integrative Health (J.P.B.), the Office of the Director (F.S.C.), and the National Center for Advancing Translational Sciences (P.K.) and Office of Extramural Research Activities (M.L.), National Institutes of Health, Bethesda, and the Centers for Medicare and Medicaid Services, Baltimore (P.H.C., A.M.S.) - all in Maryland; formerly the U.S. Army Office of the Surgeon General Pharmacovigilance Center, Falls Church, VA (T.S.C.); the Office of the Under Secretary for Health, Department of Veterans Affairs (D.J.S.), the Office of Health Policy, Office of the Assistant Secretary for Planning and Evaluation, (N.D.L., S.R.S.), the Office of the Assistant Secretary for Health (K.B.D.), and the Office of the National Coordinator for Health Information Technology (B.V.W., P.J.W.), Department of Health and Human Services, the National Academy of Medicine (V.J.D., J.M.M.), and the Patient-Centered Outcomes Research Institute (R.L.F., J.V.S.), Washington, DC; the Center for Medication Safety, Department of Veterans Affairs, Hines, IL (F.E.C.); the Department of Health Care Policy, Harvard University (R.G.F.), the Million Veteran Program, Veterans Affairs Boston Healthcare System-Division of Aging, Brigham and Women's Hospital and Harvard Medical School (J.M.G.), and the Department of Surgery, Boston University School of Medicine (J. Woodson), Boston; and the Office of Public Health Scientific Services, Centers for Disease Control and Prevention, Atlanta (C.R.)., DeSalvo KB; From the Office of the Commissioner (R.M.C., R.E.S.) and the Centers for Drug Evaluation and Research (M.A.R., J. Woodcock), Biologics Evaluation and Research (P.W.M.), and Devices and Radiological Health (J.S.), Food and Drug Administration, Silver Spring, the Office of the Director (A.B.B.) and the Center for Evidence and Practice Improvement (C.D.), Agency for Healthcare Research and Quality, Rockville, the National Center for Complementary and Integrative Health (J.P.B.), the Office of the Director (F.S.C.), and the National Center for Advancing Translational Sciences (P.K.) and Office of Extramural Research Activities (M.L.), National Institutes of Health, Bethesda, and the Centers for Medicare and Medicaid Services, Baltimore (P.H.C., A.M.S.) - all in Maryland; formerly the U.S. Army Office of the Surgeon General Pharmacovigilance Center, Falls Church, VA (T.S.C.); the Office of the Under Secretary for Health, Department of Veterans Affairs (D.J.S.), the Office of Health Policy, Office of the Assistant Secretary for Planning and Evaluation, (N.D.L., S.R.S.), the Office of the Assistant Secretary for Health (K.B.D.), and the Office of the National Coordinator for Health Information Technology (B.V.W., P.J.W.), Department of Health and Human Services, the National Academy of Medicine (V.J.D., J.M.M.), and the Patient-Centered Outcomes Research Institute (R.L.F., J.V.S.), Washington, DC; the Center for Medication Safety, Department of Veterans Affairs, Hines, IL (F.E.C.); the Department of Health Care Policy, Harvard University (R.G.F.), the Million Veteran Program, Veterans Affairs Boston Healthcare System-Division of Aging, Brigham and Women's Hospital and Harvard Medical School (J.M.G.), and the Department of Surgery, Boston University School of Medicine (J. Woodson), Boston; and the Office of Public Health Scientific Services, Centers for Disease Control and Prevention, Atlanta (C.R.)., Dymek C; From the Office of the Commissioner (R.M.C., R.E.S.) and the Centers for Drug Evaluation and Research (M.A.R., J. Woodcock), Biologics Evaluation and Research (P.W.M.), and Devices and Radiological Health (J.S.), Food and Drug Administration, Silver Spring, the Office of the Director (A.B.B.) and the Center for Evidence and Practice Improvement (C.D.), Agency for Healthcare Research and Quality, Rockville, the National Center for Complementary and Integrative Health (J.P.B.), the Office of the Director (F.S.C.), and the National Center for Advancing Translational Sciences (P.K.) and Office of Extramural Research Activities (M.L.), National Institutes of Health, Bethesda, and the Centers for Medicare and Medicaid Services, Baltimore (P.H.C., A.M.S.) - all in Maryland; formerly the U.S. Army Office of the Surgeon General Pharmacovigilance Center, Falls Church, VA (T.S.C.); the Office of the Under Secretary for Health, Department of Veterans Affairs (D.J.S.), the Office of Health Policy, Office of the Assistant Secretary for Planning and Evaluation, (N.D.L., S.R.S.), the Office of the Assistant Secretary for Health (K.B.D.), and the Office of the National Coordinator for Health Information Technology (B.V.W., P.J.W.), Department of Health and Human Services, the National Academy of Medicine (V.J.D., J.M.M.), and the Patient-Centered Outcomes Research Institute (R.L.F., J.V.S.), Washington, DC; the Center for Medication Safety, Department of Veterans Affairs, Hines, IL (F.E.C.); the Department of Health Care Policy, Harvard University (R.G.F.), the Million Veteran Program, Veterans Affairs Boston Healthcare System-Division of Aging, Brigham and Women's Hospital and Harvard Medical School (J.M.G.), and the Department of Surgery, Boston University School of Medicine (J. Woodson), Boston; and the Office of Public Health Scientific Services, Centers for Disease Control and Prevention, Atlanta (C.R.)., Dzau VJ; From the Office of the Commissioner (R.M.C., R.E.S.) and the Centers for Drug Evaluation and Research (M.A.R., J. Woodcock), Biologics Evaluation and Research (P.W.M.), and Devices and Radiological Health (J.S.), Food and Drug Administration, Silver Spring, the Office of the Director (A.B.B.) and the Center for Evidence and Practice Improvement (C.D.), Agency for Healthcare Research and Quality, Rockville, the National Center for Complementary and Integrative Health (J.P.B.), the Office of the Director (F.S.C.), and the National Center for Advancing Translational Sciences (P.K.) and Office of Extramural Research Activities (M.L.), National Institutes of Health, Bethesda, and the Centers for Medicare and Medicaid Services, Baltimore (P.H.C., A.M.S.) - all in Maryland; formerly the U.S. Army Office of the Surgeon General Pharmacovigilance Center, Falls Church, VA (T.S.C.); the Office of the Under Secretary for Health, Department of Veterans Affairs (D.J.S.), the Office of Health Policy, Office of the Assistant Secretary for Planning and Evaluation, (N.D.L., S.R.S.), the Office of the Assistant Secretary for Health (K.B.D.), and the Office of the National Coordinator for Health Information Technology (B.V.W., P.J.W.), Department of Health and Human Services, the National Academy of Medicine (V.J.D., J.M.M.), and the Patient-Centered Outcomes Research Institute (R.L.F., J.V.S.), Washington, DC; the Center for Medication Safety, Department of Veterans Affairs, Hines, IL (F.E.C.); the Department of Health Care Policy, Harvard University (R.G.F.), the Million Veteran Program, Veterans Affairs Boston Healthcare System-Division of Aging, Brigham and Women's Hospital and Harvard Medical School (J.M.G.), and the Department of Surgery, Boston University School of Medicine (J. Woodson), Boston; and the Office of Public Health Scientific Services, Centers for Disease Control and Prevention, Atlanta (C.R.)., Fleurence RL; From the Office of the Commissioner (R.M.C., R.E.S.) and the Centers for Drug Evaluation and Research (M.A.R., J. Woodcock), Biologics Evaluation and Research (P.W.M.), and Devices and Radiological Health (J.S.), Food and Drug Administration, Silver Spring, the Office of the Director (A.B.B.) and the Center for Evidence and Practice Improvement (C.D.), Agency for Healthcare Research and Quality, Rockville, the National Center for Complementary and Integrative Health (J.P.B.), the Office of the Director (F.S.C.), and the National Center for Advancing Translational Sciences (P.K.) and Office of Extramural Research Activities (M.L.), National Institutes of Health, Bethesda, and the Centers for Medicare and Medicaid Services, Baltimore (P.H.C., A.M.S.) - all in Maryland; formerly the U.S. Army Office of the Surgeon General Pharmacovigilance Center, Falls Church, VA (T.S.C.); the Office of the Under Secretary for Health, Department of Veterans Affairs (D.J.S.), the Office of Health Policy, Office of the Assistant Secretary for Planning and Evaluation, (N.D.L., S.R.S.), the Office of the Assistant Secretary for Health (K.B.D.), and the Office of the National Coordinator for Health Information Technology (B.V.W., P.J.W.), Department of Health and Human Services, the National Academy of Medicine (V.J.D., J.M.M.), and the Patient-Centered Outcomes Research Institute (R.L.F., J.V.S.), Washington, DC; the Center for Medication Safety, Department of Veterans Affairs, Hines, IL (F.E.C.); the Department of Health Care Policy, Harvard University (R.G.F.), the Million Veteran Program, Veterans Affairs Boston Healthcare System-Division of Aging, Brigham and Women's Hospital and Harvard Medical School (J.M.G.), and the Department of Surgery, Boston University School of Medicine (J. Woodson), Boston; and the Office of Public Health Scientific Services, Centers for Disease Control and Prevention, Atlanta (C.R.)., Frank RG; From the Office of the Commissioner (R.M.C., R.E.S.) and the Centers for Drug Evaluation and Research (M.A.R., J. Woodcock), Biologics Evaluation and Research (P.W.M.), and Devices and Radiological Health (J.S.), Food and Drug Administration, Silver Spring, the Office of the Director (A.B.B.) and the Center for Evidence and Practice Improvement (C.D.), Agency for Healthcare Research and Quality, Rockville, the National Center for Complementary and Integrative Health (J.P.B.), the Office of the Director (F.S.C.), and the National Center for Advancing Translational Sciences (P.K.) and Office of Extramural Research Activities (M.L.), National Institutes of Health, Bethesda, and the Centers for Medicare and Medicaid Services, Baltimore (P.H.C., A.M.S.) - all in Maryland; formerly the U.S. Army Office of the Surgeon General Pharmacovigilance Center, Falls Church, VA (T.S.C.); the Office of the Under Secretary for Health, Department of Veterans Affairs (D.J.S.), the Office of Health Policy, Office of the Assistant Secretary for Planning and Evaluation, (N.D.L., S.R.S.), the Office of the Assistant Secretary for Health (K.B.D.), and the Office of the National Coordinator for Health Information Technology (B.V.W., P.J.W.), Department of Health and Human Services, the National Academy of Medicine (V.J.D., J.M.M.), and the Patient-Centered Outcomes Research Institute (R.L.F., J.V.S.), Washington, DC; the Center for Medication Safety, Department of Veterans Affairs, Hines, IL (F.E.C.); the Department of Health Care Policy, Harvard University (R.G.F.), the Million Veteran Program, Veterans Affairs Boston Healthcare System-Division of Aging, Brigham and Women's Hospital and Harvard Medical School (J.M.G.), and the Department of Surgery, Boston University School of Medicine (J. Woodson), Boston; and the Office of Public Health Scientific Services, Centers for Disease Control and Prevention, Atlanta (C.R.)., Gaziano JM; From the Office of the Commissioner (R.M.C., R.E.S.) and the Centers for Drug Evaluation and Research (M.A.R., J. Woodcock), Biologics Evaluation and Research (P.W.M.), and Devices and Radiological Health (J.S.), Food and Drug Administration, Silver Spring, the Office of the Director (A.B.B.) and the Center for Evidence and Practice Improvement (C.D.), Agency for Healthcare Research and Quality, Rockville, the National Center for Complementary and Integrative Health (J.P.B.), the Office of the Director (F.S.C.), and the National Center for Advancing Translational Sciences (P.K.) and Office of Extramural Research Activities (M.L.), National Institutes of Health, Bethesda, and the Centers for Medicare and Medicaid Services, Baltimore (P.H.C., A.M.S.) - all in Maryland; formerly the U.S. Army Office of the Surgeon General Pharmacovigilance Center, Falls Church, VA (T.S.C.); the Office of the Under Secretary for Health, Department of Veterans Affairs (D.J.S.), the Office of Health Policy, Office of the Assistant Secretary for Planning and Evaluation, (N.D.L., S.R.S.), the Office of the Assistant Secretary for Health (K.B.D.), and the Office of the National Coordinator for Health Information Technology (B.V.W., P.J.W.), Department of Health and Human Services, the National Academy of Medicine (V.J.D., J.M.M.), and the Patient-Centered Outcomes Research Institute (R.L.F., J.V.S.), Washington, DC; the Center for Medication Safety, Department of Veterans Affairs, Hines, IL (F.E.C.); the Department of Health Care Policy, Harvard University (R.G.F.), the Million Veteran Program, Veterans Affairs Boston Healthcare System-Division of Aging, Brigham and Women's Hospital and Harvard Medical School (J.M.G.), and the Department of Surgery, Boston University School of Medicine (J. Woodson), Boston; and the Office of Public Health Scientific Services, Centers for Disease Control and Prevention, Atlanta (C.R.)., Kaufmann P; From the Office of the Commissioner (R.M.C., R.E.S.) and the Centers for Drug Evaluation and Research (M.A.R., J. Woodcock), Biologics Evaluation and Research (P.W.M.), and Devices and Radiological Health (J.S.), Food and Drug Administration, Silver Spring, the Office of the Director (A.B.B.) and the Center for Evidence and Practice Improvement (C.D.), Agency for Healthcare Research and Quality, Rockville, the National Center for Complementary and Integrative Health (J.P.B.), the Office of the Director (F.S.C.), and the National Center for Advancing Translational Sciences (P.K.) and Office of Extramural Research Activities (M.L.), National Institutes of Health, Bethesda, and the Centers for Medicare and Medicaid Services, Baltimore (P.H.C., A.M.S.) - all in Maryland; formerly the U.S. Army Office of the Surgeon General Pharmacovigilance Center, Falls Church, VA (T.S.C.); the Office of the Under Secretary for Health, Department of Veterans Affairs (D.J.S.), the Office of Health Policy, Office of the Assistant Secretary for Planning and Evaluation, (N.D.L., S.R.S.), the Office of the Assistant Secretary for Health (K.B.D.), and the Office of the National Coordinator for Health Information Technology (B.V.W., P.J.W.), Department of Health and Human Services, the National Academy of Medicine (V.J.D., J.M.M.), and the Patient-Centered Outcomes Research Institute (R.L.F., J.V.S.), Washington, DC; the Center for Medication Safety, Department of Veterans Affairs, Hines, IL (F.E.C.); the Department of Health Care Policy, Harvard University (R.G.F.), the Million Veteran Program, Veterans Affairs Boston Healthcare System-Division of Aging, Brigham and Women's Hospital and Harvard Medical School (J.M.G.), and the Department of Surgery, Boston University School of Medicine (J. Woodson), Boston; and the Office of Public Health Scientific Services, Centers for Disease Control and Prevention, Atlanta (C.R.)., Lauer M; From the Office of the Commissioner (R.M.C., R.E.S.) and the Centers for Drug Evaluation and Research (M.A.R., J. Woodcock), Biologics Evaluation and Research (P.W.M.), and Devices and Radiological Health (J.S.), Food and Drug Administration, Silver Spring, the Office of the Director (A.B.B.) and the Center for Evidence and Practice Improvement (C.D.), Agency for Healthcare Research and Quality, Rockville, the National Center for Complementary and Integrative Health (J.P.B.), the Office of the Director (F.S.C.), and the National Center for Advancing Translational Sciences (P.K.) and Office of Extramural Research Activities (M.L.), National Institutes of Health, Bethesda, and the Centers for Medicare and Medicaid Services, Baltimore (P.H.C., A.M.S.) - all in Maryland; formerly the U.S. Army Office of the Surgeon General Pharmacovigilance Center, Falls Church, VA (T.S.C.); the Office of the Under Secretary for Health, Department of Veterans Affairs (D.J.S.), the Office of Health Policy, Office of the Assistant Secretary for Planning and Evaluation, (N.D.L., S.R.S.), the Office of the Assistant Secretary for Health (K.B.D.), and the Office of the National Coordinator for Health Information Technology (B.V.W., P.J.W.), Department of Health and Human Services, the National Academy of Medicine (V.J.D., J.M.M.), and the Patient-Centered Outcomes Research Institute (R.L.F., J.V.S.), Washington, DC; the Center for Medication Safety, Department of Veterans Affairs, Hines, IL (F.E.C.); the Department of Health Care Policy, Harvard University (R.G.F.), the Million Veteran Program, Veterans Affairs Boston Healthcare System-Division of Aging, Brigham and Women's Hospital and Harvard Medical School (J.M.G.), and the Department of Surgery, Boston University School of Medicine (J. Woodson), Boston; and the Office of Public Health Scientific Services, Centers for Disease Control and Prevention, Atlanta (C.R.)., Marks PW; From the Office of the Commissioner (R.M.C., R.E.S.) and the Centers for Drug Evaluation and Research (M.A.R., J. Woodcock), Biologics Evaluation and Research (P.W.M.), and Devices and Radiological Health (J.S.), Food and Drug Administration, Silver Spring, the Office of the Director (A.B.B.) and the Center for Evidence and Practice Improvement (C.D.), Agency for Healthcare Research and Quality, Rockville, the National Center for Complementary and Integrative Health (J.P.B.), the Office of the Director (F.S.C.), and the National Center for Advancing Translational Sciences (P.K.) and Office of Extramural Research Activities (M.L.), National Institutes of Health, Bethesda, and the Centers for Medicare and Medicaid Services, Baltimore (P.H.C., A.M.S.) - all in Maryland; formerly the U.S. Army Office of the Surgeon General Pharmacovigilance Center, Falls Church, VA (T.S.C.); the Office of the Under Secretary for Health, Department of Veterans Affairs (D.J.S.), the Office of Health Policy, Office of the Assistant Secretary for Planning and Evaluation, (N.D.L., S.R.S.), the Office of the Assistant Secretary for Health (K.B.D.), and the Office of the National Coordinator for Health Information Technology (B.V.W., P.J.W.), Department of Health and Human Services, the National Academy of Medicine (V.J.D., J.M.M.), and the Patient-Centered Outcomes Research Institute (R.L.F., J.V.S.), Washington, DC; the Center for Medication Safety, Department of Veterans Affairs, Hines, IL (F.E.C.); the Department of Health Care Policy, Harvard University (R.G.F.), the Million Veteran Program, Veterans Affairs Boston Healthcare System-Division of Aging, Brigham and Women's Hospital and Harvard Medical School (J.M.G.), and the Department of Surgery, Boston University School of Medicine (J. Woodson), Boston; and the Office of Public Health Scientific Services, Centers for Disease Control and Prevention, Atlanta (C.R.)., McGinnis JM; From the Office of the Commissioner (R.M.C., R.E.S.) and the Centers for Drug Evaluation and Research (M.A.R., J. Woodcock), Biologics Evaluation and Research (P.W.M.), and Devices and Radiological Health (J.S.), Food and Drug Administration, Silver Spring, the Office of the Director (A.B.B.) and the Center for Evidence and Practice Improvement (C.D.), Agency for Healthcare Research and Quality, Rockville, the National Center for Complementary and Integrative Health (J.P.B.), the Office of the Director (F.S.C.), and the National Center for Advancing Translational Sciences (P.K.) and Office of Extramural Research Activities (M.L.), National Institutes of Health, Bethesda, and the Centers for Medicare and Medicaid Services, Baltimore (P.H.C., A.M.S.) - all in Maryland; formerly the U.S. Army Office of the Surgeon General Pharmacovigilance Center, Falls Church, VA (T.S.C.); the Office of the Under Secretary for Health, Department of Veterans Affairs (D.J.S.), the Office of Health Policy, Office of the Assistant Secretary for Planning and Evaluation, (N.D.L., S.R.S.), the Office of the Assistant Secretary for Health (K.B.D.), and the Office of the National Coordinator for Health Information Technology (B.V.W., P.J.W.), Department of Health and Human Services, the National Academy of Medicine (V.J.D., J.M.M.), and the Patient-Centered Outcomes Research Institute (R.L.F., J.V.S.), Washington, DC; the Center for Medication Safety, Department of Veterans Affairs, Hines, IL (F.E.C.); the Department of Health Care Policy, Harvard University (R.G.F.), the Million Veteran Program, Veterans Affairs Boston Healthcare System-Division of Aging, Brigham and Women's Hospital and Harvard Medical School (J.M.G.), and the Department of Surgery, Boston University School of Medicine (J. Woodson), Boston; and the Office of Public Health Scientific Services, Centers for Disease Control and Prevention, Atlanta (C.R.)., Richards C; From the Office of the Commissioner (R.M.C., R.E.S.) and the Centers for Drug Evaluation and Research (M.A.R., J. Woodcock), Biologics Evaluation and Research (P.W.M.), and Devices and Radiological Health (J.S.), Food and Drug Administration, Silver Spring, the Office of the Director (A.B.B.) and the Center for Evidence and Practice Improvement (C.D.), Agency for Healthcare Research and Quality, Rockville, the National Center for Complementary and Integrative Health (J.P.B.), the Office of the Director (F.S.C.), and the National Center for Advancing Translational Sciences (P.K.) and Office of Extramural Research Activities (M.L.), National Institutes of Health, Bethesda, and the Centers for Medicare and Medicaid Services, Baltimore (P.H.C., A.M.S.) - all in Maryland; formerly the U.S. Army Office of the Surgeon General Pharmacovigilance Center, Falls Church, VA (T.S.C.); the Office of the Under Secretary for Health, Department of Veterans Affairs (D.J.S.), the Office of Health Policy, Office of the Assistant Secretary for Planning and Evaluation, (N.D.L., S.R.S.), the Office of the Assistant Secretary for Health (K.B.D.), and the Office of the National Coordinator for Health Information Technology (B.V.W., P.J.W.), Department of Health and Human Services, the National Academy of Medicine (V.J.D., J.M.M.), and the Patient-Centered Outcomes Research Institute (R.L.F., J.V.S.), Washington, DC; the Center for Medication Safety, Department of Veterans Affairs, Hines, IL (F.E.C.); the Department of Health Care Policy, Harvard University (R.G.F.), the Million Veteran Program, Veterans Affairs Boston Healthcare System-Division of Aging, Brigham and Women's Hospital and Harvard Medical School (J.M.G.), and the Department of Surgery, Boston University School of Medicine (J. Woodson), Boston; and the Office of Public Health Scientific Services, Centers for Disease Control and Prevention, Atlanta (C.R.)., Selby JV; From the Office of the Commissioner (R.M.C., R.E.S.) and the Centers for Drug Evaluation and Research (M.A.R., J. Woodcock), Biologics Evaluation and Research (P.W.M.), and Devices and Radiological Health (J.S.), Food and Drug Administration, Silver Spring, the Office of the Director (A.B.B.) and the Center for Evidence and Practice Improvement (C.D.), Agency for Healthcare Research and Quality, Rockville, the National Center for Complementary and Integrative Health (J.P.B.), the Office of the Director (F.S.C.), and the National Center for Advancing Translational Sciences (P.K.) and Office of Extramural Research Activities (M.L.), National Institutes of Health, Bethesda, and the Centers for Medicare and Medicaid Services, Baltimore (P.H.C., A.M.S.) - all in Maryland; formerly the U.S. Army Office of the Surgeon General Pharmacovigilance Center, Falls Church, VA (T.S.C.); the Office of the Under Secretary for Health, Department of Veterans Affairs (D.J.S.), the Office of Health Policy, Office of the Assistant Secretary for Planning and Evaluation, (N.D.L., S.R.S.), the Office of the Assistant Secretary for Health (K.B.D.), and the Office of the National Coordinator for Health Information Technology (B.V.W., P.J.W.), Department of Health and Human Services, the National Academy of Medicine (V.J.D., J.M.M.), and the Patient-Centered Outcomes Research Institute (R.L.F., J.V.S.), Washington, DC; the Center for Medication Safety, Department of Veterans Affairs, Hines, IL (F.E.C.); the Department of Health Care Policy, Harvard University (R.G.F.), the Million Veteran Program, Veterans Affairs Boston Healthcare System-Division of Aging, Brigham and Women's Hospital and Harvard Medical School (J.M.G.), and the Department of Surgery, Boston University School of Medicine (J. Woodson), Boston; and the Office of Public Health Scientific Services, Centers for Disease Control and Prevention, Atlanta (C.R.)., Shulkin DJ; From the Office of the Commissioner (R.M.C., R.E.S.) and the Centers for Drug Evaluation and Research (M.A.R., J. Woodcock), Biologics Evaluation and Research (P.W.M.), and Devices and Radiological Health (J.S.), Food and Drug Administration, Silver Spring, the Office of the Director (A.B.B.) and the Center for Evidence and Practice Improvement (C.D.), Agency for Healthcare Research and Quality, Rockville, the National Center for Complementary and Integrative Health (J.P.B.), the Office of the Director (F.S.C.), and the National Center for Advancing Translational Sciences (P.K.) and Office of Extramural Research Activities (M.L.), National Institutes of Health, Bethesda, and the Centers for Medicare and Medicaid Services, Baltimore (P.H.C., A.M.S.) - all in Maryland; formerly the U.S. Army Office of the Surgeon General Pharmacovigilance Center, Falls Church, VA (T.S.C.); the Office of the Under Secretary for Health, Department of Veterans Affairs (D.J.S.), the Office of Health Policy, Office of the Assistant Secretary for Planning and Evaluation, (N.D.L., S.R.S.), the Office of the Assistant Secretary for Health (K.B.D.), and the Office of the National Coordinator for Health Information Technology (B.V.W., P.J.W.), Department of Health and Human Services, the National Academy of Medicine (V.J.D., J.M.M.), and the Patient-Centered Outcomes Research Institute (R.L.F., J.V.S.), Washington, DC; the Center for Medication Safety, Department of Veterans Affairs, Hines, IL (F.E.C.); the Department of Health Care Policy, Harvard University (R.G.F.), the Million Veteran Program, Veterans Affairs Boston Healthcare System-Division of Aging, Brigham and Women's Hospital and Harvard Medical School (J.M.G.), and the Department of Surgery, Boston University School of Medicine (J. Woodson), Boston; and the Office of Public Health Scientific Services, Centers for Disease Control and Prevention, Atlanta (C.R.)., Shuren J; From the Office of the Commissioner (R.M.C., R.E.S.) and the Centers for Drug Evaluation and Research (M.A.R., J. Woodcock), Biologics Evaluation and Research (P.W.M.), and Devices and Radiological Health (J.S.), Food and Drug Administration, Silver Spring, the Office of the Director (A.B.B.) and the Center for Evidence and Practice Improvement (C.D.), Agency for Healthcare Research and Quality, Rockville, the National Center for Complementary and Integrative Health (J.P.B.), the Office of the Director (F.S.C.), and the National Center for Advancing Translational Sciences (P.K.) and Office of Extramural Research Activities (M.L.), National Institutes of Health, Bethesda, and the Centers for Medicare and Medicaid Services, Baltimore (P.H.C., A.M.S.) - all in Maryland; formerly the U.S. Army Office of the Surgeon General Pharmacovigilance Center, Falls Church, VA (T.S.C.); the Office of the Under Secretary for Health, Department of Veterans Affairs (D.J.S.), the Office of Health Policy, Office of the Assistant Secretary for Planning and Evaluation, (N.D.L., S.R.S.), the Office of the Assistant Secretary for Health (K.B.D.), and the Office of the National Coordinator for Health Information Technology (B.V.W., P.J.W.), Department of Health and Human Services, the National Academy of Medicine (V.J.D., J.M.M.), and the Patient-Centered Outcomes Research Institute (R.L.F., J.V.S.), Washington, DC; the Center for Medication Safety, Department of Veterans Affairs, Hines, IL (F.E.C.); the Department of Health Care Policy, Harvard University (R.G.F.), the Million Veteran Program, Veterans Affairs Boston Healthcare System-Division of Aging, Brigham and Women's Hospital and Harvard Medical School (J.M.G.), and the Department of Surgery, Boston University School of Medicine (J. Woodson), Boston; and the Office of Public Health Scientific Services, Centers for Disease Control and Prevention, Atlanta (C.R.)., Slavitt AM; From the Office of the Commissioner (R.M.C., R.E.S.) and the Centers for Drug Evaluation and Research (M.A.R., J. Woodcock), Biologics Evaluation and Research (P.W.M.), and Devices and Radiological Health (J.S.), Food and Drug Administration, Silver Spring, the Office of the Director (A.B.B.) and the Center for Evidence and Practice Improvement (C.D.), Agency for Healthcare Research and Quality, Rockville, the National Center for Complementary and Integrative Health (J.P.B.), the Office of the Director (F.S.C.), and the National Center for Advancing Translational Sciences (P.K.) and Office of Extramural Research Activities (M.L.), National Institutes of Health, Bethesda, and the Centers for Medicare and Medicaid Services, Baltimore (P.H.C., A.M.S.) - all in Maryland; formerly the U.S. Army Office of the Surgeon General Pharmacovigilance Center, Falls Church, VA (T.S.C.); the Office of the Under Secretary for Health, Department of Veterans Affairs (D.J.S.), the Office of Health Policy, Office of the Assistant Secretary for Planning and Evaluation, (N.D.L., S.R.S.), the Office of the Assistant Secretary for Health (K.B.D.), and the Office of the National Coordinator for Health Information Technology (B.V.W., P.J.W.), Department of Health and Human Services, the National Academy of Medicine (V.J.D., J.M.M.), and the Patient-Centered Outcomes Research Institute (R.L.F., J.V.S.), Washington, DC; the Center for Medication Safety, Department of Veterans Affairs, Hines, IL (F.E.C.); the Department of Health Care Policy, Harvard University (R.G.F.), the Million Veteran Program, Veterans Affairs Boston Healthcare System-Division of Aging, Brigham and Women's Hospital and Harvard Medical School (J.M.G.), and the Department of Surgery, Boston University School of Medicine (J. Woodson), Boston; and the Office of Public Health Scientific Services, Centers for Disease Control and Prevention, Atlanta (C.R.)., Smith SR; From the Office of the Commissioner (R.M.C., R.E.S.) and the Centers for Drug Evaluation and Research (M.A.R., J. Woodcock), Biologics Evaluation and Research (P.W.M.), and Devices and Radiological Health (J.S.), Food and Drug Administration, Silver Spring, the Office of the Director (A.B.B.) and the Center for Evidence and Practice Improvement (C.D.), Agency for Healthcare Research and Quality, Rockville, the National Center for Complementary and Integrative Health (J.P.B.), the Office of the Director (F.S.C.), and the National Center for Advancing Translational Sciences (P.K.) and Office of Extramural Research Activities (M.L.), National Institutes of Health, Bethesda, and the Centers for Medicare and Medicaid Services, Baltimore (P.H.C., A.M.S.) - all in Maryland; formerly the U.S. Army Office of the Surgeon General Pharmacovigilance Center, Falls Church, VA (T.S.C.); the Office of the Under Secretary for Health, Department of Veterans Affairs (D.J.S.), the Office of Health Policy, Office of the Assistant Secretary for Planning and Evaluation, (N.D.L., S.R.S.), the Office of the Assistant Secretary for Health (K.B.D.), and the Office of the National Coordinator for Health Information Technology (B.V.W., P.J.W.), Department of Health and Human Services, the National Academy of Medicine (V.J.D., J.M.M.), and the Patient-Centered Outcomes Research Institute (R.L.F., J.V.S.), Washington, DC; the Center for Medication Safety, Department of Veterans Affairs, Hines, IL (F.E.C.); the Department of Health Care Policy, Harvard University (R.G.F.), the Million Veteran Program, Veterans Affairs Boston Healthcare System-Division of Aging, Brigham and Women's Hospital and Harvard Medical School (J.M.G.), and the Department of Surgery, Boston University School of Medicine (J. Woodson), Boston; and the Office of Public Health Scientific Services, Centers for Disease Control and Prevention, Atlanta (C.R.)., Washington BV; From the Office of the Commissioner (R.M.C., R.E.S.) and the Centers for Drug Evaluation and Research (M.A.R., J. Woodcock), Biologics Evaluation and Research (P.W.M.), and Devices and Radiological Health (J.S.), Food and Drug Administration, Silver Spring, the Office of the Director (A.B.B.) and the Center for Evidence and Practice Improvement (C.D.), Agency for Healthcare Research and Quality, Rockville, the National Center for Complementary and Integrative Health (J.P.B.), the Office of the Director (F.S.C.), and the National Center for Advancing Translational Sciences (P.K.) and Office of Extramural Research Activities (M.L.), National Institutes of Health, Bethesda, and the Centers for Medicare and Medicaid Services, Baltimore (P.H.C., A.M.S.) - all in Maryland; formerly the U.S. Army Office of the Surgeon General Pharmacovigilance Center, Falls Church, VA (T.S.C.); the Office of the Under Secretary for Health, Department of Veterans Affairs (D.J.S.), the Office of Health Policy, Office of the Assistant Secretary for Planning and Evaluation, (N.D.L., S.R.S.), the Office of the Assistant Secretary for Health (K.B.D.), and the Office of the National Coordinator for Health Information Technology (B.V.W., P.J.W.), Department of Health and Human Services, the National Academy of Medicine (V.J.D., J.M.M.), and the Patient-Centered Outcomes Research Institute (R.L.F., J.V.S.), Washington, DC; the Center for Medication Safety, Department of Veterans Affairs, Hines, IL (F.E.C.); the Department of Health Care Policy, Harvard University (R.G.F.), the Million Veteran Program, Veterans Affairs Boston Healthcare System-Division of Aging, Brigham and Women's Hospital and Harvard Medical School (J.M.G.), and the Department of Surgery, Boston University School of Medicine (J. Woodson), Boston; and the Office of Public Health Scientific Services, Centers for Disease Control and Prevention, Atlanta (C.R.)., White PJ; From the Office of the Commissioner (R.M.C., R.E.S.) and the Centers for Drug Evaluation and Research (M.A.R., J. Woodcock), Biologics Evaluation and Research (P.W.M.), and Devices and Radiological Health (J.S.), Food and Drug Administration, Silver Spring, the Office of the Director (A.B.B.) and the Center for Evidence and Practice Improvement (C.D.), Agency for Healthcare Research and Quality, Rockville, the National Center for Complementary and Integrative Health (J.P.B.), the Office of the Director (F.S.C.), and the National Center for Advancing Translational Sciences (P.K.) and Office of Extramural Research Activities (M.L.), National Institutes of Health, Bethesda, and the Centers for Medicare and Medicaid Services, Baltimore (P.H.C., A.M.S.) - all in Maryland; formerly the U.S. Army Office of the Surgeon General Pharmacovigilance Center, Falls Church, VA (T.S.C.); the Office of the Under Secretary for Health, Department of Veterans Affairs (D.J.S.), the Office of Health Policy, Office of the Assistant Secretary for Planning and Evaluation, (N.D.L., S.R.S.), the Office of the Assistant Secretary for Health (K.B.D.), and the Office of the National Coordinator for Health Information Technology (B.V.W., P.J.W.), Department of Health and Human Services, the National Academy of Medicine (V.J.D., J.M.M.), and the Patient-Centered Outcomes Research Institute (R.L.F., J.V.S.), Washington, DC; the Center for Medication Safety, Department of Veterans Affairs, Hines, IL (F.E.C.); the Department of Health Care Policy, Harvard University (R.G.F.), the Million Veteran Program, Veterans Affairs Boston Healthcare System-Division of Aging, Brigham and Women's Hospital and Harvard Medical School (J.M.G.), and the Department of Surgery, Boston University School of Medicine (J. Woodson), Boston; and the Office of Public Health Scientific Services, Centers for Disease Control and Prevention, Atlanta (C.R.)., Woodcock J; From the Office of the Commissioner (R.M.C., R.E.S.) and the Centers for Drug Evaluation and Research (M.A.R., J. Woodcock), Biologics Evaluation and Research (P.W.M.), and Devices and Radiological Health (J.S.), Food and Drug Administration, Silver Spring, the Office of the Director (A.B.B.) and the Center for Evidence and Practice Improvement (C.D.), Agency for Healthcare Research and Quality, Rockville, the National Center for Complementary and Integrative Health (J.P.B.), the Office of the Director (F.S.C.), and the National Center for Advancing Translational Sciences (P.K.) and Office of Extramural Research Activities (M.L.), National Institutes of Health, Bethesda, and the Centers for Medicare and Medicaid Services, Baltimore (P.H.C., A.M.S.) - all in Maryland; formerly the U.S. Army Office of the Surgeon General Pharmacovigilance Center, Falls Church, VA (T.S.C.); the Office of the Under Secretary for Health, Department of Veterans Affairs (D.J.S.), the Office of Health Policy, Office of the Assistant Secretary for Planning and Evaluation, (N.D.L., S.R.S.), the Office of the Assistant Secretary for Health (K.B.D.), and the Office of the National Coordinator for Health Information Technology (B.V.W., P.J.W.), Department of Health and Human Services, the National Academy of Medicine (V.J.D., J.M.M.), and the Patient-Centered Outcomes Research Institute (R.L.F., J.V.S.), Washington, DC; the Center for Medication Safety, Department of Veterans Affairs, Hines, IL (F.E.C.); the Department of Health Care Policy, Harvard University (R.G.F.), the Million Veteran Program, Veterans Affairs Boston Healthcare System-Division of Aging, Brigham and Women's Hospital and Harvard Medical School (J.M.G.), and the Department of Surgery, Boston University School of Medicine (J. Woodson), Boston; and the Office of Public Health Scientific Services, Centers for Disease Control and Prevention, Atlanta (C.R.)., Woodson J; From the Office of the Commissioner (R.M.C., R.E.S.) and the Centers for Drug Evaluation and Research (M.A.R., J. Woodcock), Biologics Evaluation and Research (P.W.M.), and Devices and Radiological Health (J.S.), Food and Drug Administration, Silver Spring, the Office of the Director (A.B.B.) and the Center for Evidence and Practice Improvement (C.D.), Agency for Healthcare Research and Quality, Rockville, the National Center for Complementary and Integrative Health (J.P.B.), the Office of the Director (F.S.C.), and the National Center for Advancing Translational Sciences (P.K.) and Office of Extramural Research Activities (M.L.), National Institutes of Health, Bethesda, and the Centers for Medicare and Medicaid Services, Baltimore (P.H.C., A.M.S.) - all in Maryland; formerly the U.S. Army Office of the Surgeon General Pharmacovigilance Center, Falls Church, VA (T.S.C.); the Office of the Under Secretary for Health, Department of Veterans Affairs (D.J.S.), the Office of Health Policy, Office of the Assistant Secretary for Planning and Evaluation, (N.D.L., S.R.S.), the Office of the Assistant Secretary for Health (K.B.D.), and the Office of the National Coordinator for Health Information Technology (B.V.W., P.J.W.), Department of Health and Human Services, the National Academy of Medicine (V.J.D., J.M.M.), and the Patient-Centered Outcomes Research Institute (R.L.F., J.V.S.), Washington, DC; the Center for Medication Safety, Department of Veterans Affairs, Hines, IL (F.E.C.); the Department of Health Care Policy, Harvard University (R.G.F.), the Million Veteran Program, Veterans Affairs Boston Healthcare System-Division of Aging, Brigham and Women's Hospital and Harvard Medical School (J.M.G.), and the Department of Surgery, Boston University School of Medicine (J. Woodson), Boston; and the Office of Public Health Scientific Services, Centers for Disease Control and Prevention, Atlanta (C.R.)., Sherman RE; From the Office of the Commissioner (R.M.C., R.E.S.) and the Centers for Drug Evaluation and Research (M.A.R., J. Woodcock), Biologics Evaluation and Research (P.W.M.), and Devices and Radiological Health (J.S.), Food and Drug Administration, Silver Spring, the Office of the Director (A.B.B.) and the Center for Evidence and Practice Improvement (C.D.), Agency for Healthcare Research and Quality, Rockville, the National Center for Complementary and Integrative Health (J.P.B.), the Office of the Director (F.S.C.), and the National Center for Advancing Translational Sciences (P.K.) and Office of Extramural Research Activities (M.L.), National Institutes of Health, Bethesda, and the Centers for Medicare and Medicaid Services, Baltimore (P.H.C., A.M.S.) - all in Maryland; formerly the U.S. Army Office of the Surgeon General Pharmacovigilance Center, Falls Church, VA (T.S.C.); the Office of the Under Secretary for Health, Department of Veterans Affairs (D.J.S.), the Office of Health Policy, Office of the Assistant Secretary for Planning and Evaluation, (N.D.L., S.R.S.), the Office of the Assistant Secretary for Health (K.B.D.), and the Office of the National Coordinator for Health Information Technology (B.V.W., P.J.W.), Department of Health and Human Services, the National Academy of Medicine (V.J.D., J.M.M.), and the Patient-Centered Outcomes Research Institute (R.L.F., J.V.S.), Washington, DC; the Center for Medication Safety, Department of Veterans Affairs, Hines, IL (F.E.C.); the Department of Health Care Policy, Harvard University (R.G.F.), the Million Veteran Program, Veterans Affairs Boston Healthcare System-Division of Aging, Brigham and Women's Hospital and Harvard Medical School (J.M.G.), and the Department of Surgery, Boston University School of Medicine (J. Woodson), Boston; and the Office of Public Health Scientific Services, Centers for Disease Control and Prevention, Atlanta (C.R.).
Publikováno v:
The New England journal of medicine [N Engl J Med] 2016 Dec 15; Vol. 375 (24), pp. 2395-2400.
Publikováno v:
The New England journal of medicine [N Engl J Med] 2007 Jun 07; Vol. 356 (23), pp. 2422-4; author reply 2422-4.
Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation.
Autor:
Hylek EM; General Medicine Division, Clinical Epidemiology Unit, Massachusetts General Hospital, Harvard Medical School, Boston 02114, USA., Go AS, Chang Y, Jensvold NG, Henault LE, Selby JV, Singer DE
Publikováno v:
The New England journal of medicine [N Engl J Med] 2003 Sep 11; Vol. 349 (11), pp. 1019-26.